Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Enhanc3D Genomics
Enhanced Genomics is a biotechnology therapeutics discovery and development company that uniquely defines causal biology from disease-associated variants on a genome-wide scale. Leveraging their…
Enhanc3D Genomics
Enhanced Genomics is a biotechnology therapeutics discovery and development company that uniquely defines causal biology from disease-associated variants on a genome-wide scale. Leveraging their…
TL;DR
Headquarters: Cambridge, UK
Core tech: Proprietary 3D multi-omics platform and cell type–specific atlas
Founders: Prof. Peter Fraser; Dr. Stefan Schoenfelder
Focus: Target discovery for common diseases, emphasis on autoimmune indications
Recent funding: Series A announced Oct 20, 2022
Company Overview
Problem Domain
Translating genetic association data (including non-coding variants) into causal biology to improve drug target identification and clinical trial stratification.
Founded
2020
Industry
Biotechnology / Therapeutics discovery
Funding Track Record
Non-dilutive grant (Johnson & Johnson Robotics and Digital Solutions referenced)
11220000.00
Series A announced Oct 20, 2022; some reporting lists an extended Series A amount of $19M
Investor Signal
“Bioqube Ventures; Parkwalk Advisors; Business Growth Fund; Meltwind Advisory”